{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:59:53Z","timestamp":1768280393374,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.thromres.2011.06.013","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T04:23:24Z","timestamp":1310012604000},"page":"e67-e72","source":"Crossref","is-referenced-by-count":9,"title":["Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo"],"prefix":"10.1016","volume":"128","author":[{"given":"Johannes J.","family":"Sidelmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven O.","family":"Skouby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"Kluft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Vitzthum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Gram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.06.013_bb0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00001721-199912000-00004","article-title":"A protease isolated from human plasma activating factor VII independent of tissue factor","volume":"10","author":"Roemisch","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2011.06.013_bb0010","first-page":"292","article-title":"The FVII activating protease cleaves single-chain plasminogen activators","volume":"29","author":"Roemisch","year":"1999","journal-title":"Haemostasis"},{"key":"10.1016\/j.thromres.2011.06.013_bb0015","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1515\/BC.2002.121","article-title":"Factor VII activating protease (FSAP): a novel protease in hemostasis","volume":"383","author":"Roemisch","year":"2002","journal-title":"Biol Chem"},{"key":"10.1016\/j.thromres.2011.06.013_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/187152509789105444","article-title":"Human plasma kallikrein-kinin system: physiological and biochemical parameters","volume":"7","author":"Bryant","year":"2009","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.thromres.2011.06.013_bb0025","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1515\/BC.2002.184","article-title":"The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin","volume":"383","author":"Etscheid","year":"2002","journal-title":"Biol Chem"},{"key":"10.1016\/j.thromres.2011.06.013_bb0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.atherosclerosis.2007.03.042","article-title":"Factor Seven Activating Protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques","volume":"196","author":"Parahuleva","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2011.06.013_bb0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00001721-200207000-00008","article-title":"The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP)","volume":"13","author":"Roemisch","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2011.06.013_bb0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH06-01-0023","article-title":"Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism","volume":"95","author":"Hoppe","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.06.013_bb0045","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.thromres.2008.02.002","article-title":"Factor VII-activating protease in patients with acute deep venous thrombosis","volume":"122","author":"Sidelmann","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.06.013_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH05-09-0601","article-title":"Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism","volume":"95","author":"Gulesserian","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.06.013_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1160\/TH07-10-0607","article-title":"Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry","author":"Pecheniuk","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.06.013_bb0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/13697131003597027","article-title":"Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women","volume":"13","author":"Sidelmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.thromres.2011.06.013_bb0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.maturitas.2005.01.004","article-title":"The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis","volume":"52","author":"Eilertsen","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.thromres.2011.06.013_bb0070","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1067\/mob.2002.122414","article-title":"Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations","volume":"186","author":"Skouby","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2011.06.013_bb0075","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2011.06.013_bb0080","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.06.013_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.contraception.2005.01.006","article-title":"A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel","volume":"72","author":"Jespersen","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2011.06.013_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2011.06.013_bb0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-7824(99)00044-X","article-title":"An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group","volume":"59","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2011.06.013_bb0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001721-200107000-00007","article-title":"Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects","volume":"12","author":"Roemisch","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2011.06.013_bb0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1515\/CCLM.2008.218","article-title":"Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP","volume":"46","author":"Stephan","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.thromres.2011.06.013_bb0110","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1055\/s-0037-1613089","article-title":"Internal quality control of PCR-based genotyping methods in research studies and patient diagnostics","volume":"87","author":"Bladbjerg","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.06.013_bb0115","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ob.1998.v179.a92633","article-title":"Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review","volume":"179","author":"Winkler","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2011.06.013_bb0120","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1016\/j.thromres.2010.03.003","article-title":"Factor Seven Activating Protease (FSAP) levels during normal pregnancy and in women using oral contraceptives","volume":"126","author":"Parahuleva","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.06.013_bb0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1160\/TH07-10-0640","article-title":"Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis","volume":"99","author":"Kanse","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.06.013_bb0130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-0038-1650651","article-title":"Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives","volume":"76","author":"Quehenberger","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.06.013_bb0135","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S0010-7824(00)00148-7","article-title":"Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism","volume":"62","author":"Winkler","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2011.06.013_bb0140","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1182\/blood-2005-02-0576","article-title":"The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis","volume":"105","author":"van Minkelen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.06.013_bb0145","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth Analg"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811003008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811003008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T16:24:16Z","timestamp":1560356656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811003008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0049384811003008"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.06.013","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}